Osteoarthritis (OA), the most common type of arthritis, is a degenerative joint disease.
Introduction
Osteoarthritis (OA), which is also known as osteoarthroses or degenerative joint disease, is the most common type of arthritis worldwide [1] [2] [3] . OA is characterized by the erosion of articular cartilage, which leads to joint-space narrowing, subchondral sclerosis, subchondral cysts, synovial inflammation, and marginal osteophyte formation [2, 4] . Individuals with OA can suffer from pain, muscle weakness, decreasing ranges of motion, and increasing disability. Documented contributors to this pathophysiology include genetic predisposition, trauma, inflammation, and metabolic changes [2, 5, 6] .
Hyaluronate or hyaluronic acid (HA) is a high molecular weight glycosaminoglycan (GAG) composed of repeating disaccharide units of N-acetylglucosamine and glucuronic acid [7] . HA is the most abundant GAG in mammalian tissues, and is present at high concentrations in connective tissues, such as skin, cartilage, vitreous humor and umbilical cord. The largest single reservoir of HA is the synovial fluid (SF) of the diarthrodial joints, where concentrations of 0.5-4 mg/ml are achieved [1, 8] and HA has been shown to mediate the elastic properties and viscosity of SF. Notably, however, the concentration and molecular weight of HA are dramatically reduced in OA joints [9, 10] . Intra-articular injection of HA (IAHA) has been accepted as an effective therapy for OA and several trials have attempted to evaluate the benefits of IAHA for knee OA (e.g., improvements in painful knee movements and general pain relief) [9, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . HA has a very short half-life (12 to 17 h) once injected into the joint, but its clinical effects can last six to 12 months [7, 15] . Thus, HA appears to provide its clinical benefits by providing viscous fluid replacement and triggering multifunctional biological responses.
Reactive oxygen species (ROS), such as hydrogen peroxide (H 2 O 2 ), hypochlorite ion (OCl − ), hydroxyl radical (UOH) and superoxide anion (O 2 − ), are derived from oxygen and involve in both normal intracellular signal transduction and degenerative cellular processes [21, 22] . Elevated production of ROS and/or depletion of antioxidants has been observed in a variety of pathological conditions, including inflammatory joint diseases [22] [23] [24] . Specifically, studies have shown that chondrocyte apoptosis and articular cartilage degradation can be caused by elevated ROS production, contributing to the aging of cartilage and the pathogenesis of OA [21] [22] [23] [25] [26] [27] . Recently, Miki et al. demonstrated that HA treatment could attenuate mechanical stress-enhanced ROS synthesis and reverse proteoglycan synthesis inhibited by mechanical stress in bovine cartilage, supporting the antioxidant activity of HA [28] . However, we do not yet fully understand the molecular mechanisms through which HA offers its chondroprotective effects under oxidative stress. Here, we report that the levels of H 2 O 2 and O 2 − in the SF of OA patients were significantly reduced following IAHA therapy, and that external HA treatment of human OA chondrocytes suppressed H 2 O 2 -induced cell death in vitro. To gain new insights into the HA-regulated proteins that contribute to its chondroprotective effects under oxidative stress, we used 2-DE combined with mass spectrometry to identify proteins that were differentially expressed in OA chondrocytes treated with H 2 O 2 and/or HA. The obtained candidate proteins included subsets involved in stress, apoptosis/anti-apoptosis and protein synthesis, indicating that HA plays multiple biological roles in OA chondrocytes under oxidative stress. . Chondrocytes were maintained in DMEM (Invitrogen, Carlsbad, CA, USA) supplemented with 100 units/ml penicillin/streptomycin (Invitrogen), 1% glutamine and 10% FCS at 37°C in a humidified atmosphere of 95% air/5% CO 2 . When the monolayers were 90% confluent, the cells were recovered by trypsinization (P0), seeded onto 100-mm or 150-mm culture plates, and subjected to RNA/protein extraction up to the third passage (P1-P3). The chondrocytic nature of the cells was confirmed by determination of collagen type I and type II expressions using reverse transcription polymerase chain reaction (RT-PCR) and quantitative PCR.
Materials and methods

Patient population and clinical specimens
RNA extraction, RT-PCR and quantitative PCR
Total RNA was extracted using the TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Total RNA was measured by absorbance at 260 nm, and subjected to RT-PCR with a SuperScript III kit (Invitrogen). The utilized primers are as follows: collagen type II sense, 5′-CAACCAGATTGAGAGA GCATCC-3′ and antisense, 5′-TGTTTCGTGCAGCCATCCTT-3′; and GAPDH (endogenous control) sense, 5′-GCCAAAAGGG TCATCATCTC-3′ and antisense, 5′-GGCCATCCACAGTCTTCT-3′. The PCR conditions consisted of a single incubation step at 95°C for 3 min, followed by 25 cycles of 40 s at 95°C, 30 s at 60°C and 45 s at 72°C. The RT-PCR products were analyzed by electrophoresis in 1.5% agarose gels containing ethidium bromide. Real-time quantitative PCR (qPCR) was performed on a 20 μl reaction mixture containing 100 nM forward and reverse primers, varying amounts of template and 2 × SYBR Green I reaction mix (KAPA SYBR FAST qPCR Kit, Boston, MA, USA). The primers used in this study were designed using Primer Express Software (Applied Biosystems, Foster City, CA, USA) and the sequences listed in Supplementary Table S2 . SYBR Green fluorescence intensity was determined using the Bio-Red MyiQ 5 detection system (Bio-Rad Laboratories Inc., Hercules, CA, USA), and the gene level normalized against that of the18S rRNA as an internal control gene.
Chondrocytic protein preparation
Chondrocytes were recovered from culture plates by trypsinization, washed twice with PBS in microcentrifuge tubes, and subjected to centrifugation. The cell pellets were solubilized by vortexing followed by incubation for 1 h with gentle agitation in lysis buffer containing 30 mM Tris, 7 M urea, 2 M thiourea, 4% CHAPS, and 1% dithiothreitol (DTT), pH 8.5. To improve the performance of 2-DE, the crude extracted proteins were subjected to methanol/chloroform precipitation. Briefly, 400 μl methanol and 100 μl chloroform were added sequentially into 100 μl of chondrocytic proteins. The mixture was vortexed, supplemented with 300 μl double-distilled water, and vortexed again. After centrifugation at 14,000 g for 2 min, the top aqueous layer was pipetted off and 400 μl of methanol was added to the organic layer. The protein fraction was obtained by centrifugation at 14,000 g for 3 min, and solubilized in rehydration buffer (8 M urea, 2 M thiourea, 2% IPG buffer and 130 mM DTT). The chondrocytic protein solutions prepared from each individual were quantified using the Bradford protein assay (Bio-Rad Laboratories Inc).
2-DE and image analysis
For the first-dimensional separation of chondrocytic proteins, 300 μg of chondrocytic proteins was subjected to isoelectric focusing on 18-cm immobilized pH 3-10, non-liner IPG strips (GE Healthcare, Uppsala, Sweden) using the cup-loading approach for a total of 80 kVh on an IPGphor II (GE Healthcare) at 20°C. For reduction and alkylation, the strips were equilibrated with equilibration buffer (6 M urea, 30% glycerol, 2% SDS, 0.1 M Tris-HCl, pH 8.0, Bromophenol blue dye) containing 1% DTT (w/v) for 15 min, and then incubated with equilibration buffer containing 2.5% iodoacetamide for 
In-gel digestion
For protein identification, the silver-nitrate-stained protein spots were excised and subjected to in-gel tryptic digestion. Briefly, each gel piece was first destained with freshly prepared 1% potassium ferricyanide and 1.6% sodium thiosulfate (Sigma-Aldrich), washed with 100 mM NH 4 HCO 3 and 50% acetonitrile, dehydrated in 100% acetonitrile, and vacuum dried in a Speed-Vac centrifuge (Savant Instruments, Holbrook, COL II/COL I ratio 1.E+00
1.E-01
1.E-02
1.E-03
1.E-04 NY, USA). The dehydrated gel pieces were then subjected to digestion with sequencing-grade modified porcine trypsin (Promega, Madison, WI, USA) overnight at 37°C. Peptides were extracted with acetonitrile, and dried in a SpeedVac.
B E
Reverse phase liquid chromatography-tandem mass spectrometry
The protein identification was performed by LC-MS/MS as previously described [29] . Briefly, each peptide mixture was reconstituted in HPLC buffer A (0.1% formic acid, Sigma, St. Louis, MO, USA), loaded into a trap column (Zorbax 300SB-C18, 0. Internal calibration was performed using the ion signal of (Si(CH3)2O)6H + at m/z 445.120025 as a lock mass [30] . The data-dependent procedure that alternated between one MS scan followed by six MS/MS scans for the six most abundant precursor ions in the MS survey scan was applied. The m/z values selected for MS/MS were dynamically excluded for 180 s. The electrospray voltage applied was 1.8 kV. Both MS and MS/MS spectra were acquired using the one microscan with a maximum fill-time of 1000 and 100 ms for MS and MS/MS analysis, respectively. Automatic gain control was used to prevent over-filling of the ion trap, 5 × 10 4 ions were accumulated in the ion trap for generation of MS/MS spectra. 
Database searching and bioinformatics
The resulting MS/MS spectra were searched using the Mascot search engine (version 2.2.06, Matrix Science, London, UK) against the UniProtKB/Swiss-Prot database (selected for Homo sapiens, 20,367 entries). The search parameters were set as follows: carbamidomethylation (C) as the fixed modification, oxidation (M), N-acetyl (protein) and pyro-Glu/Gln (N-term) as variable modifications, 10 ppm for MS tolerance, 0.5 Da for MS/MS tolerance, and 2 for missing cleavage. The validation of MS/Ms based peptides and protein identifications was performed by the Scaffold proteome software (Version _3_03_02, Proteome Software Inc., Portland, OR), in which the cutoffs for peptide thresholds were 95.0% minimum, and protein thresholds were 95.0% minimum and minimum of 2 peptides. Total spectral count value and sequence coverage for each protein were used to compare the relative protein levels (abundance) in peptide mixture derived from one protein spot. The protein with the most abundance within one peptide mixture was referred to one protein spot identity. The identified proteins were further analyzed by using ProteinCenter (Proxeon Bioinformatics, Odense, Denmark), a proteomics data mining and management software, in which the identified proteins were functionally classified based on universal Gene Ontology (GO) annotation terms, and linked to at least one annotation term within the GO molecular function and biological process categories, respectively.
Cell viability assay
Cell viability was evaluated with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenytetrazolium bromide (MTT) colorimetric growth assays, as described previously [31] . Briefly, primary cultured chondrocytes (5 × 10 4 cells/well) were plated to 12-well plates and cultured for the indicated durations with or without H 2 O 2 and/or HA. Following culture, the cells were incubated with MTT solution (5 mg/ml) (Invitrogen) at 37°C for 1 h. The supernatant was aspirated, the cells were treated with DMSO, and absorbance was measured at 540 nm using an ELISA reader (SpectraMax M2; Molecular Devices, Sunnyvale, CA).
Determination of H 2 O 2 concentration by colorimetric method
The concentration of H 2 O 2 was determined by a H 2 O 2 colorimetric assay kit (Sigma-Aldrich) according to the manufacturer's instructions.
Immunofluorescence microscopy
Chondrocytes were grown on coverslips within 12-well plates, fixed with 4% paraformaldehyde, and subjected to indirect immunofluorescence staining, as described previously [32] . The cells were blocked with 0.2% bovine serum albumin and 0.1% saponin in PBS, followed by incubation with an anti-CD44 antibody (193-020; Ancell, Bayport, MN, USA). After three washes with PBS, the cells were exposed to an Alexa 594-conjugated anti-mouse IgG secondary antibody (Molecular Probes, Eugene, OR) and Hoechst 33258 dye (Invitrogen) for visualization of nuclei. Finally, the cells were mounted in 90% glycerol in PBS containing 1 mg/ml of ρ-phenylenediamine and observed under a Zeiss Axio Imager Z1 microscope (Carl Zeiss, Gottingen, Germany). [33] . Briefly, freshly aspirated SF samples were immediately wrapped in aluminum foil and placed on ice, and analyses were usually done within 4 h. Chemiluminescence measurements were performed in the completely dark chamber of a Chemiluminescence Analyzing System (CLA-SP2, Tohoku Electronic Ind. Co., Sendai, Japan). After a 100-s determination of the background level, 1.0 ml of 0.1 mM lucigenin in PBS (pH 7.4) or 1.0 ml of mM luminol was injected into the sample, and chemiluminescence was continuously monitored for 600 s. The area under the curve was integrated, the background was subtracted, and the obtained value represented the total amount of chemiluminescence. The assay was performed in duplicate for each sample. The results were expressed as chemiluminescence counts/10 s, and are given as the mean ± standard error of the mean (SEM).
Western blotting
Total protein extracts of OA chondrocytes were subjected to SDS-PAGE and Western blot analysis using primary antibodies against COL II (MAB1330; Millipore, Billerica, MA, USA), COMP (ab128893; Abcam plc, Cambridge, England), TALDO (sc-51440; Santa Cruz Biotechnology, Santa Cruz, CA, USA), ANXA1 (sc-1923; Santa Cruz) and EF2 (A3806; R&D Systems, Minneapolis, MN, USA). Bound IgG antibodies were detected with horseradish peroxidase-labeled secondary antibodies (GE Healthcare), visualized using chemiluminescent substrate (PerkinElmer, Inc., Waltham, MA, USA), and then exposed to X-ray film. The resulting images were acquired by Personal Densitometer SI (Molecular Dynamics), and quantified by ImageQuant tool 3.0 software (GE Healthcare).
Statistical analysis
The statistical package, GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, USA), was used for all analyses. All continuous variables were expressed as means ± SEM. Multiple comparisons were performed with one-way ANOVA. The Tukey honestly significant difference (Tukey HSD) test was used as a post-test for pairwise comparisons after one-way ANOVA. A p value of 0.05 or less was considered significant. and exerts its chondroprotective effects through HA-receptor mediated signaling, we used primary cultured chondrocytes from OA patients as a model for our experiments. Since collagen type II (COL II) is a typical marker of differentiated chondrocytes, while collagen type I (COL I) expression increases during dedifferentiation, the ratio of mRNA levels of collagen type II to I (COL II/ COL I) has been used as chondrocyte differentiation index [37] . To monitor the differentiated/de-differentiated status of primary cultured chondrocytes used in this study, we determined the mRNA levels of COL I and COL II in chondrocytes by real time, quantitative RT-PCR and calculated the COL II/COL I ratio in chondrocytes. Fig. 2A showed that monolayer culture induced a decrease in COL II and an increase in COL I. The COL II/COL I ratio declined steadily, in which 200-fold and 2000-fold decreases at first and secondary passage were observed compared to that determined in the beginning of the culture, respectively (Fig. 2B) . These results were consistent with the previous reports that chondrocyte is dedifferentiated during monolayer culture [38] . To confirm the chondrocytic property of the primary cultured cells used in this study, we used agarose gel containing ethidium bromide to detect the gene expressions of COL II at different time points in monolayer culture (Fig. 2C) . Accordingly, we used the first three passages (P1-P3) that showed distinct expressions of COL II for further experiments. We also detected two marker proteins of the chondrocyte phenotype, COL II and cartilage oligomeric matrix protein (COMP), by Western blotting. Fig. 2D showed that both of COL II and COMP proteins were expressed and detected in our cultured OA chondrocytes. Next, we examined the expression of CD44, the cell surface receptor for HA binding, on the cultured chondrocytes by immunofluorescence staining with a specific anti-CD44 antibody. As shown in Fig. 2E, CD44 was expressed on the cell surfaces of chondrocytes. We then treated these chondrocytes with various doses of H 2 O 2 for 24 h, and used MTT assays to determine the IC50 of H 2 O 2 in these cells. Our chondrocytes proved to be ROS-sensitive, as 0.9 mM and 1.1 mM H 2 0 2 decreased cell viability to 70% and 10%, respectively (Fig. 3A) . To examine the chondroprotective effects of HA on H 2 O 2 -induced cell death, we cultured chondrocytes in 12-well plates, treated them with various doses of HA with or without 1 mM H 2 O 2 for 24 h, and performed MTT assays. As shown in Fig. 3B , cell viability was unchanged among chondrocytes singly treated with HA (1.5-24 μg/ml), but HA can rescue the cell death caused by H 2 O 2 . This rescue was significant for low doses of HA (3-6 μg/ml), and was not enhanced by higher doses of HA (12-24 μg/ml). Regardless of mechanism, we propose that HA may have a bell-shaped effect on the suppression of H 2 O 2 -induced cell death in OA chondrocyte. It means that the chondroprotective effect of HA under oxidative condition would be in a concentration dependent manner.
Results and discussions
To rule out the possibility that HA can directly reduce oxidative stress, we determined the H 2 O 2 concentration in a cell-free system, in which H 2 O 2 (1 mM) was added into PBS with or without HA treatments (6 μg/ml). Fig. 3C showed that HA indeed did not reduce the level of H 2 O 2 (50.35 vs. 49.60 μg/ml) in vitro. When we added H 2 O 2 into complete culture media (DMEM) with or without HA, the H 2 O 2 level decreased to 60% of its initial level in the control medium at the starting time point, suggesting that components of the medium acted as direct antioxidant/ROS scavengers (Fig. 3D) . The H 2 O 2 levels in the complete culture medium decreased to 18.7% and 2.5% of the initial level after 2 and 24 h of incubation, respectively. This result reflects the short half-life of H 2 O 2 in vitro. Notably, the addition of HA did not further alter the levels of H 2 O 2 in this cell-free system (Fig. 3D) . Thus, our results strongly suggest that HA does not neutralize H 2 O 2 directly in our in vitro system and support our hypothesis that HA reduces ROS and exerts its chondroprotective effects through intracellular signaling pathway.
3.3. Identifying HA-regulated proteins responsible for the chondroprotective effects of HA under oxidative stress As we found that HA treatment has chondroprotective effect under oxidative stress conditions, we attempted to understand the potential mechanisms responsible for this effect using proteomic approaches. A schematic diagram of the experimental workflow is shown in Fig. 4A . Briefly, chondrocytes obtained from four OA patients were cultured to 90% confluence in 150-mm dishes and treated with H 2 O 2 and/or HA. After 24 h, cells were lysed and subjected to 2-DE analysis, and the ImageMaster™ 2D Platinum v7.0 software was used to perform between-gel comparative image analyses. The differentially expressed protein spots were subjected to in-gel digestion and identified by mass spectrometry. To determine the biological functions of the identified proteins, ProteinCenter software based on universal GO annotation terms was used. Proteins of interest were selected and verified by Western blot analysis. Following the experimental workflow, approximate 720 protein spots (range, 645-797) were detected in the silver-stained 2-DE gels (Fig. 4B) . The detected spot numbers of each gel obtained from four OA patients are listed in Supplementary Table S3 . The statistical analysis of spot quantification revealed that 13 and 5 Fig. 5A . d %Vol, the relative volume of a spot is calculated using the formula:
where Vol S is the volume of spot S in a gel containing n spots. e Average volume ratio, HA/H 2 O 2 co-treatment to H 2 O 2 single treatment. f Theoretical molecular weight (Mr) and pI according to Mascot search result using UniProtKB/Swiss-Prot database.
protein spots were significantly changed (p < 0.05, one-way ANOVA), in H 2 O 2 -and HA-treated chondrocytes compared to untreated controls, respectively. This limited overlap of differential protein profiles among four OA patients suggests that the H 2 O 2 and/or HA may have heterogeneous effects on OA chondrocytes. However, we could not rule out the possibility that inherent gel-to-gel and staining variability in 2-DE contribute to this discrepancy. These spots were excised from the gels, subjected to tryptic digestion, and identified by LC-MS/MS. Details of spot quantification and protein identification for these differentially expressed proteins regulated by H 2 O 2 or HA are summarized in Supplementary Table S4 and S5. Next, comparison of the 2-DE images obtained from H 2 O 2 -and HA/ H 2 O 2 -treated cells yielded 13 differently expressed protein spots (p < 0.05, one-way ANOVA), including 7 up-regulated and 6 down-regulated protein spots (Fig. 5A) . The relative volume values of these 13 differentially expressed protein spots on the 2-DE gels obtained from each OA patient were shown in Supplementary Table S6 . These spots were excised from the gels, subjected to tryptic digestion, and identified by LC-MS/MS. Table 1 showed the details of the spot quantification (spot mated ID, %Vol, mean squared deviation, coefficient variation, p value, and ratio) and protein identification (protein accession number, protein name, molecular weight (Mr), isoelectric point (pI), identification probability, mass score, number of unique peptides, number of total spectra, and percentage of sequence coverage), for each differently expressed protein spot.
To our knowledge, the most well-documented chondrocyte proteomes in the literature are those reported by research teams led by Blanco, Deforce, and Elewaut, who established useful protein datasets for normal, pathological (OA, inflammation-, stress-and hypoxia-induced) and pharmacologically treated chondrocytes [27, [39] [40] [41] [42] [43] [44] [45] [46] [47] . Our present data largely overlapped with the previous 10 proteome datasets. To assess the potential biological functions of the proteins found to be regulated by HA in OA chondrocytes under oxidative stress, ProteinCenter software based on universal GO annotation terms was used. These proteins were linked to at least one annotation term within the GO molecular function and biological process categories, respectively. The most common molecular functions were determined as protein binding (30%), catalytic activity (20%), nucleotide binding (13.33%) and RNA-binding (13.33%) (Fig. 5B) . The major biological process categories included metabolic processes (17.54%), cell organization and biogenesis (12.28%), regulation of biological processes (10.53%), response to stimulus (10.53%) and transport (10.53%) (Fig. 5C ).
Western blot-based validation of HA-regulated proteins in OA chondrocytes
To search the promising candidates regulated by HA, we validated the changes in three proteins that were differentially expressed with high reproducibility in all four OA patients: transaldolase (TALDO), annexin A1 (ANXA1) and Multiple comparisons and post-tests were performed as described in Fig. 3A ; *, p < 0.05.
glutathione levels [49] . In addition, reduced level of TALDO in Jurkat T cells was shown to increase glucose 6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activity, increase NADPH synthesis and glutathione levels, and decrease the levels of reactive oxygen intermediates [49] . TALDO also affects cell survival by regulating caspase 3 activity and the exposure of phosphatidylserine [49, 50] . TALDO thus plays role in the recycling of glucose 6-phosphate via the PPP, reduction-oxidation reactions, and cell apoptosis [48, 51] . Here, we found that two protein spots corresponding to TALDO were identified as a HA-regulated protein under oxidative stress (Fig. 6A and Table 1 ). Western blotting showed that the expressions of TALDO were up-regulated in H 2 O 2 treated OA chondrocytes with an average of 1.72-fold compared to control cells, but this effect was significantly suppressed by HA/H 2 O 2 co-treatment ( Fig. 6B and C) . These results were similar to that obtained from 2-DE analysis ( Table 1 , spot no. 4 and 5), suggesting that HA triggers the anti-oxidative and anti-apoptotic effects of TALDO as part of its chondroprotective effects. ANXA1, a member of the annexin protein family, is a calcium/phospholipid-binding protein that involves in exocytosis, inflammatory signaling, cell proliferation and apoptosis [52] [53] [54] [55] . Overexpression of ANXA1 suppresses cell proliferation, while its knockdown reduced cell apoptosis, supporting its role in cell survival [53, 56, 57] . Here, the average expression levels of ANXA1 in H 2 O 2 -treated OA chondrocytes were 1.52-fold higher than those in control cells (Fig. 6B and C) . In contrast, cells co-treated with HA and H 2 O 2 showed that ANXA1 expression levels were similar to those in control cells (Fig. 6B and C) . Thus, HA abolished the H 2 O 2 -induced up-regulation of ANXA1 potentially explaining the positive effects of HA on cell survival under oxidative stress.
EF2, one of the critical enzymes governing the elongation of nascent proteins, is a member of the GTP-binding elongation factor family that is involved in protein biosynthesis. Together with its kinase (EF2 kinase), EF2 tightly controls the GTPdependent ribosomal translocation step during the elongation phase of protein synthesis, and modulates the cell cycle [58] . A recent study demonstrated that EF2 overexpression suppresses the caspase 3 and 9-mediated apoptosis, and cytochrome C release induced by HIV-1 viral protein R, further supporting the notion that EF2 processes anti-apoptotic activity [59] . The expression levels of EF2 in HA/H 2 O 2 -treated cells were a little bit increased (1.25-fold), compared to that in H 2 O 2 -treated cells (Fig. 6B and C) . This result was inconstant with that obtained from our 2-DE analysis, in which EF2 was down-regulated by H 2 O 2 and this regulation was significantly rescued by HA treatment (Table 1 , spot no. 9). However, three protein spots corresponding to EF2 were further identified by LC-MS/MS (Fig. 6A) . These multiple spots might reflect post-translational modification (PTM) of EF2, such as phosphorylation, ADPribosylation and oxidation. Unfortunately, the antibody used in our Western blotting (Fig. 6B) could not distinguish these three EF2 isoforms that might result in the discrepancy of our results obtained from 2-DE and Western blotting. Because protein synthesis may be inhibited by oxidative stress via EF2 [60, 61] , future studies are warranted to identify the PTM status of EF2 under oxidative stress and following HA treatment. This could help us understand the roles of PTM in the action of HA and provide further insights into the chondroprotective effects of HA.
Conclusions
We herein demonstrate that IAHA suppresses ROS levels (i.e., H 2 O 2 and O 2 − ) in the SF of OA patients, and provide the first overview of HA-induced proteomic changes in human OA chondrocytes under oxidative stress. Our results further indicate the HA-mediated chondroprotection through multiple intracellular regulations. The HA-mediated differential expressions of three proteins (TALDO, ANXA1 and EF2) were verified by Western blotting and the results support the notion that HA acts via multiple biological processes, including anti-oxidation, anti-apoptosis, promotion of protein synthesis, and cell survival. This study has several limitations, including de-differentiation of chondrocytes during monolayer culture, the heterogeneity of clinical characteristics of OA patients, the different passages of chondrocytes used in discovery/validation phases, and the inherent gel-to-gel variability in 2-DE analysis. Although future work is warranted to study the molecular regulations and interaction networks regulated by HA, the 12 proteins found to be differently expressed in HA/H 2 O 2 -treated cells versus H 2 O 2 --treated cells should be considered viable candidates for conferring the chondroprotective effects of HA.
